This article is more than 5 years old. Information may no longer be current.
No complications seen at midterm follow-up of cementless THA in patients with hemophilia
Click Here to Manage Email Alerts
Investigators reported 100% implant survivorship at midterm follow-up in patients with hemophilia who underwent total hip arthroplasty using a cementless implant.
In collaboration with the Agency for Haemophilia and Bleeding Disorders, researchers treated 23 patients with hemophilia with a cementless total hip arthroplasty (THA) between 2000 and 2012. The patients had a mean age of 40.6 years.
Overall, results showed no failures and no complications at a mean follow-up of about 8 years. Mean Haemophilia Joint Health Score decreased from 12.5 preoperatively to 1.5 postoperatively, according to study results. Researchers also found improved symptoms and reduced functional impairment in all cases. They also reported no complaints from patients at 6 months, and no flexion contractures of the hip or significant limitations in range of motion. Results showed 100% overall implant survivorship at last follow-up for all patients.
“A multidisciplinary team and the use of modern cementless implants may represent the keys to achieve good outcomes, fewer complications and better survivorship in the approach to these difficult cases,” the authors wrote. – by Casey Tingle
Disclosures: The researchers report no relevant financial disclosures.
Click Here to Manage Email Alerts